IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 213 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,885 | -69.8% | 1,338 | -66.7% | 0.00% | -100.0% |
| Q2 2023 | $42,709 | +27.9% | 4,014 | +26.5% | 0.00% | 0.0% |
| Q1 2023 | $33,380 | +646.3% | 3,173 | +778.9% | 0.00% | – |
| Q4 2022 | $4,473 | -10.5% | 361 | -20.5% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 454 | -41.5% | 0.00% | – |
| Q2 2022 | $9,000 | +50.0% | 776 | +68.3% | 0.00% | – |
| Q1 2022 | $6,000 | +20.0% | 461 | +9.8% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 420 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 420 | -19.1% | 0.00% | – |
| Q2 2021 | $7,000 | +40.0% | 519 | +27.2% | 0.00% | – |
| Q1 2021 | $5,000 | +66.7% | 408 | +61.3% | 0.00% | – |
| Q4 2020 | $3,000 | +50.0% | 253 | -7.3% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 273 | +326.6% | 0.00% | – |
| Q2 2020 | $1,000 | – | 64 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |